These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 29140767)

  • 1. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
    Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
    OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. David Bowie and the Art of Slow Innovation: A Fast-Second Winner Strategy for Biotechnology and Precision Medicine Global Development.
    Özdemir V; Patrinos GP
    OMICS; 2017 Nov; 21(11):633-637. PubMed ID: 29064337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges.
    Tekola-Ayele F; Rotimi CN
    Public Health Genomics; 2015; 18(4):242-7. PubMed ID: 26138992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Success stories in genomic medicine from resource-limited countries.
    Mitropoulos K; Al Jaibeji H; Forero DA; Laissue P; Wonkam A; Lopez-Correa C; Mohamed Z; Chantratita W; Lee MT; Llerena A; Brand A; Ali BR; Patrinos GP
    Hum Genomics; 2015 Jun; 9(1):11. PubMed ID: 26081768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance Ratio Based Resource Allocation Decision-Making in Genomic Medicine.
    Fragoulakis V; Mitropoulou C; Katelidou D; van Schaik RH; Maniadakis N; Patrinos GP
    OMICS; 2017 Feb; 21(2):67-73. PubMed ID: 28118098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology to improve health in developing countries -- a review.
    Acharya T; Kennedy R; Daar AS; Singer PA
    Mem Inst Oswaldo Cruz; 2004 Jun; 99(4):341-50. PubMed ID: 15322621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing genomics and biotechnology to improve global health equity.
    Singer PA; Daar AS
    Science; 2001 Oct; 294(5540):87-9. PubMed ID: 11588248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing Global Precision Medicine: An Overview of Genomic Testing and Counseling Services in Malaysia.
    Balasopoulou A; Mooy FM; Baker DJ; Mitropoulou C; Skoufas E; Bulgiba A; Katsila T; Patrinos GP
    OMICS; 2017 Dec; 21(12):733-740. PubMed ID: 29173101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics innovation: transforming healthcare, business, and the global economy.
    Jimenez-Sanchez G
    Genome; 2015 Dec; 58(12):511-7. PubMed ID: 26632961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and genomics: the scientific drivers of personalized medicine.
    Kurnat-Thoma EL
    Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).
    Ozdemir V; Endrenyi L; Aynacıoğlu S; Bragazzi NL; Dandara C; Dove ES; Ferguson LR; Geraci CJ; Hafen E; Kesim BE; Kolker E; Lee EJ; Llerena A; Nacak M; Shimoda K; Someya T; Srivastava S; Tomlinson B; Vayena E; Warnich L; Yaşar U
    OMICS; 2014 Apr; 18(4):211-21. PubMed ID: 24649998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions.
    Klein ME; Parvez MM; Shin JG
    J Pharm Sci; 2017 Sep; 106(9):2368-2379. PubMed ID: 28619604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoiding the genomics divide.
    Calva E; Cardosa MJ; Gavilondo JV
    Trends Biotechnol; 2002 Sep; 20(9):368-70. PubMed ID: 12175761
    [No Abstract]   [Full Text] [Related]  

  • 15. Public Funding for Genomics and the Return on Investment: A Public Health Perspective.
    Hyder A
    Perspect Biol Med; 2018; 61(4):572-583. PubMed ID: 30613039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation science, genomic precision medicine, and improved health: A new path forward?
    Williams JK; Feero WG; Leonard DG; Coleman B
    Nurs Outlook; 2017; 65(1):36-40. PubMed ID: 27633263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How can developing countries harness biotechnology to improve health?
    Daar AS; Berndtson K; Persad DL; Singer PA
    BMC Public Health; 2007 Dec; 7():346. PubMed ID: 18053180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying genomics-related technologies for Africa's health needs.
    Singer PA; Court EB; Bhatt A; Frew SE; Greenwood H; Persad DL; Salamanca-Buentello F; Séguin B; Taylor AD; Daer HT; Daar AS
    Afr J Med Med Sci; 2007; 36 Suppl():7-14. PubMed ID: 17703557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine Goes Global: How to Get It Right? Four Ways to Mobilize Scientific Knowledge.
    Özdemir V
    OMICS; 2018 Aug; 22(8):539-543. PubMed ID: 30004300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
    Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
    Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.